In our latest Leader Insights interview, Dr Himanshu Gadgil, CEO of Enzene Biosciences, joins Drug Discovery and Development to share his roadmap for navigating the industry’s toughest challenges in 2027.
From skyrocketing R&D costs to complex regulatory hurdles, Dr Gadgil breaks down how the sector is evolving and the impact of AI in drug discovery and development and what biotechs are asking for more frequently. He discusses what is possible with AI and reveals how Enzene’s cutting-edge AI platform is addressing these problems by transforming early-stage discovery into a faster, more predictable science.
Click play to watch the full video.
